Skip to content

Clinical trials

Phase 3 Eczema trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Eczema Phase: Phase 3 Country / region: United States Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20142
20151
20173
20189
20194
20205
20213
20225
20236
20242
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Recruiting4
Terminated4
Active, not recruiting2
Withdrawn2
Enrolling by invitation1
Unknown status1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company13
Pfizer11
Incyte Corporation6
Organon and Co4
Amgen3
Regeneron Pharmaceuticals3
Vanda Pharmaceuticals2
Cara Therapeutics, Inc.1
Johnson & Johnson Consumer and Personal Products Worldwide1
NeoStrata Company, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Eczema46
Dermatitis, Atopic42
Dermatitis13
Skin Diseases13
Pruritus6
Immune System Diseases5
Skin Diseases, Eczematous5
Skin Diseases, Genetic4
Genetic Diseases, Inborn3
Hypersensitivity3

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.